Ameritas Investment Partners, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.84 Billion
- Q2 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,263 shares of REGN stock, worth $4.44 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,263
Previous 4,272
0.21%
Holding current value
$4.44 Million
Previous $4.11 Million
8.98%
% of portfolio
0.16%
Previous 0.14%
Shares
25 transactions
Others Institutions Holding REGN
# of Institutions
1,463Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$9.37 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.63 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.05 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.83 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $112B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...